Strategic Global Advisors, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Strategic Global Advisors, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,129,627
-5.5%
11,090
-6.4%
0.19%
+2.2%
Q2 2023$1,195,380
+7.6%
11,846
-1.9%
0.18%
+3.4%
Q1 2023$1,111,360
+177.3%
12,080
+173.5%
0.18%
+178.1%
Q4 2022$400,710
+18.9%
4,417
-0.5%
0.06%
+14.3%
Q3 2022$337,000
-5.9%
4,439
+4.8%
0.06%
+1.8%
Q2 2022$358,000
-5.0%
4,236
-1.5%
0.06%0.0%
Q1 2022$377,000
-77.4%
4,301
+1.5%
0.06%
-74.5%
Q4 2021$1,670,000
-3.5%
4,239
-80.0%
0.22%
-14.6%
Q3 2021$1,730,000
-10.6%
21,151
-0.3%
0.25%
-27.9%
Q2 2021$1,935,000
-54.9%
21,210
-57.7%
0.35%
-54.5%
Q1 2021$4,287,000
-9.3%
50,149
+0.2%
0.77%
-7.5%
Q4 2020$4,724,000
+5.0%
50,024
-3.3%
0.84%
-1.3%
Q3 2020$4,500,000
+11.9%
51,751
+12.4%
0.85%
-1.6%
Q2 2020$4,023,000
+39.4%
46,059
+31.6%
0.86%
+15.9%
Q1 2020$2,886,000
+11.2%
34,997
+27.7%
0.74%
+37.7%
Q4 2019$2,595,000
+34.0%
27,409
+23.0%
0.54%
+23.3%
Q3 2019$1,937,000
-4.3%
22,290
+0.5%
0.44%
+1.2%
Q2 2019$2,025,000
-4.4%
22,182
+0.7%
0.43%
-3.1%
Q1 2019$2,118,000
+441.7%
22,032
+383.4%
0.45%
+218.6%
Q4 2018$391,000
-11.7%
4,558
-11.4%
0.14%
+4.5%
Q3 2018$443,000
+9.9%
5,147
+3.2%
0.13%
+30.1%
Q2 2018$403,0000.0%4,9870.0%0.10%
-25.4%
Q1 2018$403,000
-1.5%
4,987
+2.4%
0.14%
+3.8%
Q4 2017$409,0004,8690.13%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders